- Rockwell Medical (RMTI) says a CRUISE-1 & -2 clinical abstract has been accepted for a poster presentation at the ASN Kidney Week 2013 Annual Meeting in November. (PR)
- Although it isn't immediately clear why this particular news should be a meaningful catalyst (the shares have already rallied more than 100% since the CRUISE-2 read-out), the stock is up some 11% premarket.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs